Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

Nikhil Prasad  Fact checked by:Thailand Medical News Team Oct 30, 2023  1 month, 1 week, 4 days, 17 hours, 11 minutes ago

COVID-19 News: Taiwanese Study Shows That The Phytochemicals Dauricine And Isoliensinine Impede SARS-CoV-2 Viral Entry

facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
COVID-19 News: Taiwanese Study Shows That The Phytochemicals Dauricine And Isoliensinine Impede SARS-CoV-2 Viral Entry
Nikhil Prasad  Fact checked by:Thailand Medical News Team Oct 30, 2023  1 month, 1 week, 4 days, 17 hours, 11 minutes ago
COVID-19 News: The COVID-19 pandemic, which has continued to wreak havoc for over three years, stands as a stark reminder of the resilience and adaptability of the SARS-CoV-2 virus. This coronavirus has not only persisted but has also mutated, giving rise to various strains with different characteristics. As a result, it has maintained its dominance over societies worldwide, keeping us on our toes as we strive to develop effective countermeasures. The key to understanding and combating this virus lies in its mode of entry into human cells, which is the focus of extensive research. Recent findings from a Taiwanese study conducted at the China Medical University shed light on the potential of two phytochemicals, Dauricine and Isoliensinine, in impeding the viral entry of SARS-CoV-2. In this COVID-19 News report, we will delve into the study's findings and their implications in the broader context of COVID-19 research and therapeutics.

Asian vine Menisperum Dauricum

Understanding SARS-CoV-2 Viral Entry
SARS-CoV-2, the virus responsible for COVID-19, primarily enters human cells through the interaction between its Spike protein and host cell receptors. This interaction is a pivotal step in the infection process, and it hinges on the binding of the Spike protein to the angiotensin-converting enzyme 2 (ACE2) receptor on the surface of host cells. Subsequently, proteolytic cleavages at the S1/S2 and S2 sites of the Spike protein lead to the fusion of viral and cellular membranes, allowing the virus to enter the host cell. The cellular protease transmembrane protease, serine 2 (TMPRSS2), and the furin enzyme can cleave the polybasic insertion (PRRAR) located at the S1/S2 site, thus facilitating viral entry. Given that ACE2 and TMPRSS2 are readily accessible on the surface of host cells, disrupting the interaction between these receptors and the Spike protein offers a promising strategy for inhibiting SARS-CoV-2 infection.
The Quest for Effective Therapies
The urgency in finding effective treatments for COVID-19 is underscored by the continued spread of the virus and the emergence of new variants. While vaccines have been developed to target the viral entry process using the Spike protein, their efficacy in providing long-term protection remains a concern. Monoclonal and polyclonal antibody treatments, although effective in managing symptoms, have not proven effective in halting viral entry. In this context, the study turns to herbal medicine, particularly two herbal compounds - Dauricine and Isoliensinine, for their potential in blocking the viral entry of SARS-CoV-2.
Herbal Phytochemicals: Dauricine and Isoliensinine
Dauricine and Isoliensinine are two commonly used herbal compounds in Traditional Chinese Medicine with a wide range of indications. Dauricine, derived from the Asian vine Menisperum Dauricum or Asian moonseed, has been employed to treat various inflammatory conditions. Notably, it has demonstrated efficacy i n treating pneumonia co-infected with the influenza virus H5N1 and Streptococcus pneumoniae by inhibiting NF-κB activation. Isoliensinine, obtained from Nelumbo Nucifera Gaertn, or the lotus plant, is used in the treatment of heart-related conditions.
Research Methodology: Pseudovirus System
In their quest to evaluate the potential of Dauricine and Isoliensinine in inhibiting SARS-CoV-2 viral entry, the researchers employed a pseudovirus system. Pseudoviruses are engineered to express the Spike proteins of different variants of the virus and are incapable of replication, making them safe for research purposes. These pseudoviruses are structurally similar to the original virus, particularly in their surface proteins. This allows them to be suitable substitutes for live viruses when studying viral entry inhibition. The inclusion of a luciferase gene in pseudoviruses makes their infection quantifiable and highly reproducible, further enhancing their utility in research. This approach minimizes the risks associated with handling live SARS-CoV-2 and provides an efficient and secure means of studying viral entry.
Effective Inhibition of SARS-CoV-2 Entry
The study's results provide compelling evidence of the inhibitory effects of Dauricine and Isoliensinine on SARS-CoV-2 viral entry. These herbal compounds effectively reduced the interaction between the Spike protein and the ACE2 receptor, which is crucial for the virus to enter host cells. Importantly, these compounds did not suppress the activity of the TMPRSS2 protease, a key factor in viral entry.
Furthermore, the study evaluated the inhibitory effects of Dauricine and Isoliensinine on various variants of SARS-CoV-2. The virus has demonstrated a high degree of genetic variability, leading to the emergence of multiple distinct variants. These mutations have complicated efforts to combat the virus effectively. However, the research found that both Dauricine and Isoliensinine retained their inhibitory effects across different variants of SARS-CoV-2, emphasizing their potential as broad-spectrum therapeutic agents.
Molecular Insights: R403 Residue and Interactions
The molecular modeling conducted as part of the study revealed an interesting insight into the interactions between the herbal compounds and the Spike protein. Specifically, the study identified an interconnection between a critical residue, R403, in the Spike protein and both Dauricine and Isoliensinine. This R403 residue plays a pivotal role in the binding of the virus's Spike protein to the ACE2 receptor. The presence of R403 in the Spike protein increases its affinity for ACE2, facilitating viral entry into host cells. The study's findings suggest that Dauricine and Isoliensinine may increase the chances of reducing the Spike-ACE2 interaction by binding to R403. Additionally, hydrogen bonds involving the N407 polar residue of the Spike protein may further promote the reduction of the Spike-ACE2 interaction.
Implications and Conclusions
The fight against COVID-19 is far from over. While significant progress has been made in developing vaccines and treatments, the virus continues to evolve, posing new challenges and uncertainties. In this context, the study on Dauricine and Isoliensinine provides a promising avenue for therapeutic intervention. By focusing on blocking viral entry, these herbal compounds offer a unique approach to combating the virus. Their ability to inhibit the interaction between the Spike protein and the ACE2 receptor across different variants of SARS-CoV-2 underscores their potential as broad-spectrum therapeutic agents.
In conclusion, the ongoing battle against COVID-19 requires a multifaceted approach, with research efforts exploring various avenues. The study on Dauricine and Isoliensinine highlights the significance of herbal medicine in this fight and offers hope for more effective therapeutic interventions. While challenges persist, the adaptability of science and the dedication of researchers worldwide continue to provide new insights and strategies to confront this formidable viral adversary. The quest for effective treatments and preventive measures remains an urgent priority as we navigate the evolving landscape of the COVID-19 pandemic.
The study findings were published in the peer reviewed journal: Biomedicines.
For the latest COVID-19 News, keep on logging to Thailand Medical News.


Jun 10, 2023  6 months ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  1 year ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  1 year ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  3 years ago
Source: Supplements For COVID-19
Feb 05, 2020  4 years ago
Source : Thailand Medical news